This article was originally published in The Tan Sheet
Executive SummaryNovartis Consumer Health over-the-counter products now employ proprietary sugarless taste-masking system licensed from Cambrex under deal inked earlier this year, the life sciences company announces Nov. 9. Novartis OTCs include Triaminic cough/cold line, Maalox antacid and Theraflu line...
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.